Comparative analysis revealed that oral administration is more likely to induce gastrointestinal disorders such as pancreatitis, pancreatic cancer, belching, gastric emptying disorders, and gallstones when compared to subcutaneous injection
Treatment Treatment is symptomatic and supportive, there is no antidote
Its important to be mindful of their relationship with food, and since GLP-1s suppress appetite, this can make social occasions more difficult to navigate
Since both influence similar metabolic pathways, their overlapping mechanisms could increase the risk of side effects without significantly enhancing benefits
Women should also note that while taking any insulin-based drugs such as semaglutide, they must consider a variety of safety considerations, including blood sugar levels, before receiving their next dose and monitoring for signs of hypoglycemia due to the potential risk associated with high doses
Any diabetic patient taking SGLT2i presenting with symptoms like abdominal pain, nausea, vomiting, or fatigue should raise the suspicion of EuDKA
